Skip to main content

Table 4 Results of Cox regression analyses

From: Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

Outcome Definitive treatment n Crude hazard ratio (95% CI) Adjusted hazard ratio (95% CI)
30 day mortality Carbapenem 20 1 1
BLBLI 21 0.47 (0.09 to 2.59) 0.91 (0.13 to 6.28)*
Resolution of SIRS Carbapenem 14 1 1
BLBLI 14 1.19 (0.44 to 3.19) 0.91 (0.32 to 2.59)*
Hospital discharge Carbapenem 16 1 1
BLBLI 16 0.74 (0.38 to 1.41) 0.62 (0.27 to 1.42)*
  1. *Adjusted for ICU admission, infecting organism, Pitt score.